Litcius/Paper detail

Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases

Alaa Alhayek, Ahmed S. Abdelsamie, Esther Schönauer, Virgyl Camberlein, Evelyn Hutterer, Gernot Posselt, Jamil Serwanja, Constantin Blöchl, Christian G. Huber, Jörg Haupenthal, Hans Brandstetter, Silja Weßler, Anna K. H. Hirsch

2022Journal of Medicinal Chemistry16 citationsDOIOpen Access PDF

Abstract

larvae. The hydroxamates were also tested in a similar manner; they did not have an effect in infection models. This might be due to their fast binding kinetics to bacterial collagenases.

Topics & Concepts

CollagenaseChemistryBacillus cereusMicrobiologyRepurposingProteasesIn vitroStaphylococcus aureusPharmacologyBiochemistryEnzymeBiologyBacteriaGeneticsEcologyBiochemical and Molecular ResearchHemophilia Treatment and ResearchCancer-related gene regulation
Discovery and Characterization of Synthesized and FDA-Approved Inhibitors of Clostridial and Bacillary Collagenases | Litcius